361 related articles for article (PubMed ID: 10913382)
1. Monoclonal antibody therapy for solid tumors.
Green MC; Murray JL; Hortobagyi GN
Cancer Treat Rev; 2000 Aug; 26(4):269-86. PubMed ID: 10913382
[TBL] [Abstract][Full Text] [Related]
2. Antibody-based therapeutics in oncology.
Ross J; Gray K; Schenkein D; Greene B; Gray GS; Shulok J; Worland PJ; Celniker A; Rolfe M
Expert Rev Anticancer Ther; 2003 Feb; 3(1):107-21. PubMed ID: 12597355
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal and bispecific antibodies as novel therapeutics.
Booy EP; Johar D; Maddika S; Pirzada H; Sahib MM; Gehrke I; Loewen S; Louis SF; Kadkhoda K; Mowat M; Los M
Arch Immunol Ther Exp (Warsz); 2006; 54(2):85-101. PubMed ID: 16648969
[TBL] [Abstract][Full Text] [Related]
4. Antibodies in the therapy of colon cancer.
Welt S; Ritter G
Semin Oncol; 1999 Dec; 26(6):683-90. PubMed ID: 10606261
[TBL] [Abstract][Full Text] [Related]
5. Overview of monoclonal antibodies in cancer therapy: present and promise.
Stern M; Herrmann R
Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905
[TBL] [Abstract][Full Text] [Related]
6. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
Schlom J; Weeks MO
Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
[No Abstract] [Full Text] [Related]
7. Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors.
Capone PM; Papsidero LD; Chu TM
J Natl Cancer Inst; 1984 Mar; 72(3):673-7. PubMed ID: 6583450
[TBL] [Abstract][Full Text] [Related]
8. [Targeting therapy using monoclonal antibody directed against growth factor receptors].
Jinno H; Ueda M; Enomoto K; Ikeda T; Kitajima M
Hum Cell; 1993 Sep; 6(3):188-93. PubMed ID: 8297815
[TBL] [Abstract][Full Text] [Related]
9. Anticancer antibodies.
Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M
Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies in the treatment of lung cancer.
Egri G; Takáts A
Eur J Surg Oncol; 2006 May; 32(4):385-94. PubMed ID: 16504454
[TBL] [Abstract][Full Text] [Related]
11. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
[TBL] [Abstract][Full Text] [Related]
12. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
13. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
Liu A; Hu P; Khawli LA; Epstein AL
J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies in cancer immunotherapy.
Reisfeld RA
Clin Lab Med; 1992 Jun; 12(2):201-16. PubMed ID: 1611818
[TBL] [Abstract][Full Text] [Related]
15. Antibody-guided radiation therapy of cancer.
Koppe MJ; Postema EJ; Aarts F; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Metastasis Rev; 2005 Dec; 24(4):539-67. PubMed ID: 16408161
[TBL] [Abstract][Full Text] [Related]
16. Future prospects of monoclonal antibodies as magic bullets in immunotherapy.
Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ
Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304
[TBL] [Abstract][Full Text] [Related]
17. [Advances in medical oncology].
Shi YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):305-10. PubMed ID: 16900620
[TBL] [Abstract][Full Text] [Related]
18. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies.
Dvorak HF; Nagy JA; Dvorak AM
Cancer Cells; 1991 Mar; 3(3):77-85. PubMed ID: 1711364
[TBL] [Abstract][Full Text] [Related]
19. Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapy.
Reisfeld RA; Cheresh DA
Cancer Surv; 1985; 4(1):271-90. PubMed ID: 3916082
[No Abstract] [Full Text] [Related]
20. Immunotoxin therapy of malignancy.
Grossbard ML; Nadler LM
Important Adv Oncol; 1992; ():111-35. PubMed ID: 1582669
[No Abstract] [Full Text] [Related]
[Next] [New Search]